Discussion11 min read
AI changes the speed and economics of medical-device development, but it does not remove the need for product definition, objective evidence, competent review or manufacturer accountability.
Discussion11 min read
Why outsourcing medical-device development increases the need for intelligent manufacturer oversight—and what must be controlled before an audit or submission exposes the gaps.
Discussion9 min read
Does treatment naturally progress from infusion to injection and finally to a tablet—or can digitally supported subcutaneous delivery be the better destination?
Explained12 min read
How the responsibilities of startup founders, SME management and corporate leaders differ—and why qualified external advice is most valuable before major development commitments are made.